|

A Prospective Research Investigation of Ischemia Using MCG

RECRUITINGSponsored by SB Technology, Inc.
Actively Recruiting
SponsorSB Technology, Inc.
Started2024-07-11
Est. completion2026-03
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →

NCT06481943

Summary

PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Scheduled to undergo a diagnostic angiography or revascularization procedure for the diagnosis or treatment of ischemia or acute myocardial infarction
* Ability for participant to comply with study requirements
* Patient consented before the planned, clinically indicated cath-lab procedure begins to allow sufficient time for study related activities
* Written informed consent

Exclusion Criteria:

* Present STEMI
* Pregnant or breastfeeding
* Having an active atrial fibrillation episode as seen on most current 12-lead ECG
* Active thoracic metal implant
* Poor access to follow-up

Conditions2

Acute Coronary SyndromeHeart Disease

Locations2 sites

Minnesota

1 site
Mayo Clinic
Rochester, Minnesota, 55905
Ghasaq Saleh, MD5072552504saleh.ghasaq@mayo.edu

New York

1 site
Mount Sinai Hospital
New York, New York, 10029
Sajiny John631-750-6345sajiny.john@mountsinai.org

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.